Wolverine Trading
PDLI

Wolverine Trading’s PDL BioPharma, Inc. PDLI Stock Holding History

Wolverine Trading’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-17,903
Closed -$53K – 6534
2018
Q2 		$53K Hold
17,903
– – ﹤0.01% 4899
2018
Q1 		$53K Buy
17,903
+5,473
+44% +$14.9K ﹤0.01% 4899
2017
Q4 		$34K Buy
12,430
+1,787
+17% +$5.49K ﹤0.01% 4652
2017
Q3 		$36K Buy
+10,643
New +$29.6K ﹤0.01% 4275
2016
Q4 		– Sell
-11,125
Closed -$31K – 5750
2016
Q3 		$36K Buy
+11,125
New +$35.3K ﹤0.01% 4451

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Wolverine Trading's PDLI Position: Q3 2018 in Review

Wolverine Trading sold out of PDL BioPharma, Inc. (PDLI) in Q3 2018, closing a stake of 17,903 shares — an estimated $53K sold.

Wolverine Trading first reported a position in PDLI in Q3 2016 and held it in 5 quarters. The position peaked at $53K in Q2 2018. 152 funds tracked by Wall St. Rank hold PDLI as of Q3 2018.

  • Wolverine Trading reported no remaining PDL BioPharma, Inc. position as of Q3 2018 after selling out during the quarter.
  • Wolverine Trading sold 17,903 PDL BioPharma, Inc. shares in Q3 2018, an estimated $53K.
  • Wolverine Trading first reported a position in PDL BioPharma, Inc. in Q3 2016 and held it in 5 quarters.
  • Wolverine Trading's PDL BioPharma, Inc. position peaked at $53K in Q2 2018.
  • 152 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2018.

Based on Wolverine Trading's 13F filing for Q3 2018, filed 14 Nov 2018.